Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 247

Sort by

Sort Order Select

Journal Articles

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

Alicja Sadowska-Klasa, Sezen Ozkok, Hu Xie, Wendy Leisenring, Danniel Zamora, Sachiko Seo, Jordan Sheldon, Stephanie J. Lee, Margaret L Green, Michael Boeckh

Blood (2023) 142 (Supplement 1): 3583.

https://doi.org/10.1182/blood-2023-180305

Published: 2023

Journal Articles

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Rima M. Saliba, Stephanie J. Lee, Paul A Carpenter, Catherine J. Lee, Geoffrey R Hill, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Rohtesh S. Mehta

Blood (2023) 142 (Supplement 1): 236.

https://doi.org/10.1182/blood-2023-186402

Published: 2023

Journal Articles

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Robert Zeiser, Domenico Russo, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Nada Hamad, Xuechan Li, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli

Blood (2023) 142 (Supplement 1): 654.

https://doi.org/10.1182/blood-2023-172590

Published: 2023

Journal Articles

Prospective Clinical and Biomarker Validation of the ASTCT Consensus Definition for Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Shengling Ma, Saleh Bhar, Danielle Guffey, Rockbum Kim, Mahrukh Jamil, Maria Elizabeth Morales, Christopher I Amos, Stephanie J. Lee, Sangeeta Hingorani, Sarah E Sartain, Ang Li

Blood (2023) 142 (Supplement 1): 4902.

https://doi.org/10.1182/blood-2023-174143

Published: 2023

Journal Articles

Prediction of Graft-Versus-Host Disease (GVHD) in Recipients of Hematopoietic Cell Transplant(alloHCT) from a Single Mismatched Unrelated Donor Using a Highly Multiplexed Proteomics Assay: MHC-Pepseq

Karamjeet S. Sandhu, John Altin, Tao Wang, Jakob Devos, Medhat Askar, Zachariah DeFilipp, Ketevan Gendzekhadze, Carrie L. Kitko, Stephanie J. Lee, Margaret L. MacMillan, Stephen R. Spellman, Ryotaro Nakamura

Blood (2023) 142 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2023-186724

Published: 2023

Journal Articles

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

Richard Newcomb, Hermioni L Amonoo, Ashley M Nelson, Joanna Choe, Katherine Holmbeck, Anisa Nably, Stephanie J. Lee, Thomas W LeBlanc, Areej El-Jawahri

Blood (2023) 142 (Supplement 1): 2424.

https://doi.org/10.1182/blood-2023-179471

Published: 2023

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Mary-Elizabeth M. Percival, Ted Gooley, Chris Davis, Ryan S. Basom, Stephanie J. Lee, Frederick R. Appelbaum, Mohamed Sorror

Blood (2023) 142 (Supplement 1): 3608.

https://doi.org/10.1182/blood-2023-185037

Published: 2023

Journal Articles

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Rohtesh S. Mehta, Effie W. Petersdorf, Stephen R. Spellman, Stephanie J. Lee

Blood (2023) 142 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2023-173887

Published: 2023

Journal Articles

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su

Blood (2023) 142 (Supplement 1): 2386.

https://doi.org/10.1182/blood-2023-174554

Published: 2023

Journal Articles

Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome

Shahinaz M. Gadalla, Hormuzd Katki, Tsung-Po Lai, Casey Dagnall, Caitrin Bupp, Amy Hutchinson, James Anderson, Kyra Mendez, Stephen R. Spellman, Valerie Stewart, Sharon Savage, Stephanie J. Lee, John Levine, Wael Saber, Abraham Aviv

Blood (2023) 142 (Supplement 1): 365.

https://doi.org/10.1182/blood-2023-189396

Published: 2023

Journal Articles

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

Christine Camacho-Bydume, Tao Wang, Diego Chowell, Chirag Krishna, Brian C. Shaffer, Steven Marsh, Sophie Paczesny, Shahinaz M. Gadalla, Meilun He, Yung-Tsi Bolon, Stephen R. Spellman, Stephanie J. Lee, Katharine C. Hsu

Blood (2023) 142 (Supplement 1): 2232.

https://doi.org/10.1182/blood-2023-179543

Published: 2023

Journal Articles

Monoallelic Pathogenic Variants in Hemophagocytic Lymphohistiocytosis Genes Are Uncommon and Not Associated with Hematopoietic Cell Transplantation Outcomes in Severe Aplastic Anemia

Maryam Rafati, Lisa J McReynolds, Youjin Wang, Casey Dagnall, Belynda Hicks, Kristine Jones, Stephen R. Spellman, Meilun He, Yung-Tsi Bolon, Stephanie J. Lee, Sharon Savage, Shahinaz M. Gadalla

Blood (2023) 142 (Supplement 1): 2205.

https://doi.org/10.1182/blood-2023-181010

Published: 2023

Journal Articles

A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH) to Promote Well-Being: Randomized Controlled Feasibility and Preliminary Efficacy Trial

Hermioni L Amonoo, Michelle Guo, Elizabeth Daskalakis, Emma Deary, Stephanie J. Lee, Thomas W LeBlanc, Jeff C. Huffman, Areej El-Jawahri

Blood (2023) 142 (Supplement 1): 2203.

https://doi.org/10.1182/blood-2023-179944

Published: 2023

Journal Articles

Multi-Site Randomized Trial of Inpatient Palliative Care for Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, Thomas W LeBlanc, Alison Kavanaugh, Jason Webb, James Fausto, Lara Traeger, Joseph Greer, Vicki Jackson, Nora Horick, Zachariah Defilipp, Yi-Bin Chen, Stephanie J. Lee, Jennifer Temel

Blood (2023) 142 (Supplement 1): 913.

https://doi.org/10.1182/blood-2023-185735

Published: 2023

Journal Articles

Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

Blood (2023) 142 (Supplement 1): 1.

https://doi.org/10.1182/blood-2023-186963

Published: 2023

Journal Articles

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Blood (2023) 141 (3): 295–308.

https://doi.org/10.1182/blood.2022016916

Published: 2023

Includes: Supplemental data

Journal Articles

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials

Eduardo Rodriguez Arbolí, Catherine J. Lee, Teresa Caballero, Clara Garcia-Calderon, Carmen Martinez, Maria Aranzazu Bermudez, Lucía López Corral, Ana Triguero, Lynn E. Onstad, Stefanie Sarantopoulos, Stephanie J. Lee, Jose A. Perez-Simon

Blood (2022) 140 (Supplement 1): 10502–10504.

https://doi.org/10.1182/blood-2022-158230

Published: 2022

Journal Articles

Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection

Emily C. Liang, Lynn E. Onstad, Paul A. Carpenter, Steven A. Pergam, Stephanie J. Lee, Catherine Liu

Blood (2022) 140 (Supplement 1): 920–921.

https://doi.org/10.1182/blood-2022-157440

Published: 2022

Journal Articles

Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial

Vijaya Raj Bhatt, Valerie K Shostrom, Ayman Saad, Betty K. Hamilton, Krishna Gundabolu, Lori Maness, Virender Kumar, Ram I Mahato, Lynette M. Smith, Taiga Nishihori, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 1379–1380.

https://doi.org/10.1182/blood-2022-156340

Published: 2022

Journal Articles

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Nahid Rashid, Albert Yeh, Marco Mielcarek, Masumi Ueda Oshima, Elizabeth F Krakow, Lynn E. Onstad, Laura Connelly-Smith, Phuong Vo, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 10552–10553.

https://doi.org/10.1182/blood-2022-167820

Published: 2022

NARROW

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

MMF Is Associated with Worse OS in CMV Seropositive AML Patients Undergoing MUD HCT with Calcineurin-Inhibitor-Based Gvhd Prophylaxis

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Prospective Clinical and Biomarker Validation of the ASTCT Consensus Definition for Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Prediction of Graft-Versus-Host Disease (GVHD) in Recipients of Hematopoietic Cell Transplant(alloHCT) from a Single Mismatched Unrelated Donor Using a Highly Multiplexed Proteomics Assay: MHC-Pepseq

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

Monoallelic Pathogenic Variants in Hemophagocytic Lymphohistiocytosis Genes Are Uncommon and Not Associated with Hematopoietic Cell Transplantation Outcomes in Severe Aplastic Anemia

A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH) to Promote Well-Being: Randomized Controlled Feasibility and Preliminary Efficacy Trial

Multi-Site Randomized Trial of Inpatient Palliative Care for Hospitalized Patients Undergoing Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)

An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML

Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic Graft vs. Host Disease: A Report of Two Phase I/II Trials

Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection

Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial

Effects of Severe Acute Graft-Versus-Host Disease on Quality of Life, Medical Comorbidities and Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only